The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 500 (1) , 72-76
- https://doi.org/10.1016/j.neulet.2011.06.004
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Peripheral analgesia: Hitting pain where it hurtsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Cathepsin K inhibition reduces CTXII levels and joint pain in the guinea pig model of spontaneous osteoarthritisOsteoarthritis and Cartilage, 2010
- The Symptoms of Osteoarthritis and the Genesis of PainRheumatic Disease Clinics of North America, 2008
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M currentProceedings of the National Academy of Sciences, 2008
- GPR55: a new member of the cannabinoid receptor clan?British Journal of Pharmacology, 2007
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsBritish Journal of Pharmacology, 2007
- The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurinProceedings of the National Academy of Sciences, 2006
- The cannabinomimetic arachidonyl‐2‐chloroethylamide (ACEA) acts on capsaicin‐sensitive TRPV1 receptors but not cannabinoid receptors in rat jointsBritish Journal of Pharmacology, 2004
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993